![Abbreviations: SABA, short-acting beta agonist; SAMA, short-acting beta... | Download Scientific Diagram Abbreviations: SABA, short-acting beta agonist; SAMA, short-acting beta... | Download Scientific Diagram](https://www.researchgate.net/publication/363830140/figure/fig1/AS:11431281086071174@1664074561260/Abbreviations-SABA-short-acting-beta-agonist-SAMA-short-acting-beta-agonist-ICS.png)
Abbreviations: SABA, short-acting beta agonist; SAMA, short-acting beta... | Download Scientific Diagram
![JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations](https://www.mdpi.com/jcm/jcm-11-06623/article_deploy/html/images/jcm-11-06623-g001.png)
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
![GOLD 2011 pharmacologic management of COPD based on combined assessment... | Download Scientific Diagram GOLD 2011 pharmacologic management of COPD based on combined assessment... | Download Scientific Diagram](https://www.researchgate.net/publication/232766331/figure/fig2/AS:667591068631043@1536177522180/GOLD-2011-pharmacologic-management-of-COPD-based-on-combined-assessment-of-airflow.png)
GOLD 2011 pharmacologic management of COPD based on combined assessment... | Download Scientific Diagram
![Table 3 from Resource Use and Health Care Costs of Chronic Obstructive Pulmonary Disease in Slovakia. | Semantic Scholar Table 3 from Resource Use and Health Care Costs of Chronic Obstructive Pulmonary Disease in Slovakia. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a9e459777276a68e48f8c76f19425bdaae7a6e07/1-Table3-1.png)
Table 3 from Resource Use and Health Care Costs of Chronic Obstructive Pulmonary Disease in Slovakia. | Semantic Scholar
![Amitoj Acharya on X: "@HarjitSajjan @CPHO_Canada ?Inhaled treatment for asthma and copd? Consult doctor for sure, do not rely on following for various reasons. Level1:SABA+Montelukast? L2:SABA+SAMA,? L3: ICS+LABA or LAMA? L4: Intravenous(IV) Amitoj Acharya on X: "@HarjitSajjan @CPHO_Canada ?Inhaled treatment for asthma and copd? Consult doctor for sure, do not rely on following for various reasons. Level1:SABA+Montelukast? L2:SABA+SAMA,? L3: ICS+LABA or LAMA? L4: Intravenous(IV)](https://pbs.twimg.com/media/ESSKIW8U4AA4Yv5.jpg)
Amitoj Acharya on X: "@HarjitSajjan @CPHO_Canada ?Inhaled treatment for asthma and copd? Consult doctor for sure, do not rely on following for various reasons. Level1:SABA+Montelukast? L2:SABA+SAMA,? L3: ICS+LABA or LAMA? L4: Intravenous(IV)
![Association between inhaler use and risk of haemoptysis in patients with non‐cystic fibrosis bronchiectasis - Jang - 2015 - Respirology - Wiley Online Library Association between inhaler use and risk of haemoptysis in patients with non‐cystic fibrosis bronchiectasis - Jang - 2015 - Respirology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c53ff721-9d51-4572-bbe7-10ea86a84b20/resp12618-fig-0003-m.jpg)
Association between inhaler use and risk of haemoptysis in patients with non‐cystic fibrosis bronchiectasis - Jang - 2015 - Respirology - Wiley Online Library
![Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice. - Abstract - Europe PMC Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4664433/bin/copd-10-2535Fig1.jpg)